ASP Isotopes Inc. announced that Renergen Limited's Tetra4 subsidiary completed commissioning and achieved stable liquid helium production at the Virginia Gas Project, with first contracted deliveries planned and nameplate capacity expected during the fourth quarter of 2026.
ASPI · ASP Isotopes Inc. · Documents
$1.87
-0.09 (-4.59%)
At close · Nov 12
Return incl. dividend (before tax)
Market Cap
$286.69M
Shares
153.31M
Volume · Nov 12
3.11M
Avg daily vol (3M)
4.14M
You came from your AI assistant. Add Equibles to it and ask about this data directly, free.
The company's filings, earnings calls and investor events, most recent first. Search and read these filings from Claude or ChatGPT with the SEC filings MCP server →
2026
Oct 26
Current report
8-K
Regulation FD disclosure
Oct 15
Current report
8-K
Regulation FD disclosure
ASP Isotopes Inc.’s Quantum Leap Energy and Nuclear Energy Corporation of South Africa SOC Limited signed a binding Heads of Agreement for a joint venture to develop a HALEU test bench and commercial-scale facility at Pelindaba, with TerraPower offtake secured.
Oct 2
Current report
8-K
Regulation FD disclosure
Sep 8
Aug 20
Current report
8-K
Events of Aug 14
Entered into a material agreement, Ended a material agreement, New debt or off-balance-sheet obligation
AI summary on its way
Aug 20
Aug 18
Aug 14
Quarterly report
10-Q
FY2026 Q2, ended Jun 30
Quarterly report for FY2026 Q2
AI summary on its way
Revenue $5.12M
▲ 327.6%
Net loss $33.99M
Diluted EPS -$0.27
Aug 12
Aug 6
Aug 5
Aug 4
Jul 30
Jul 28
Jul 21
Jul 16
Jul 16
Jul 16
Current report
8-K
Events of Jul 15
Entered into a material agreement, Unregistered sale of equity, Regulation FD disclosure
AI summary on its way
Jun 25
Current report
8-K
Entered into a material agreement, Unregistered sale of equity, Regulation FD disclosure, Other events
AI summary on its way
Jun 25
Jun 23
May 26
May 20
May 20
Quarterly report
10-Q
FY2026 Q1, ended Mar 31
Quarterly report for FY2026 Q1
AI summary on its way
Revenue $4.18M
▲ 279.3%
Net loss $7.12M
Diluted EPS -$0.06
May 15
May 11
May 6
Apr 30
Annual report
10-K/A
Ended Dec 31
Annual report for the period ended Dec 31, 2025
AI summary on its way
Apr 13
Apr 13
Apr 10
Annual report
10-K
FY2025, ended Dec 31
Annual report for FY2025
AI summary on its way
Revenue $23.85M
▲ 475.5%
Net loss $159.84M
Diluted EPS -$2.11
Apr 10
Mar 31
Mar 24
Mar 24
Mar 23
Mar 10
Mar 6
Mar 5
Feb 23
Feb 19
Feb 17
Jan 30
Jan 29
Jan 12
Current report
8-K
Events of Jan 6
Director or officer change, or executive pay
AI summary on its way
Jan 7
Current report
8-K
Events of Jan 6
Completed an acquisition or sale of assets, Unregistered sale of equity, Other events
AI summary on its way
2025
Dec 19
Current report
8-K
Events of Dec 18
Shareholder vote results
Dec 18
Current report
8-K
Regulation FD disclosure
Dec 17
Current report
8-K
Other events
Dec 8
Current report
8-K
Events of Dec 2
Director or officer change, or executive pay
Showing 1–50 of 169 documents
Key facts
CIK
1921865
CUSIP
00218A105
13F (30d)
107 filings
85 filers
Visit website
Investor relations